Atraumatic Clostridial myonecrosis: case report and literature review.

B. Abella,Paulina Kuchinic,T. Hiraoka,D. Howes

DOI: https://doi.org/10.1016/S0736-4679(03)00037-4

IF: 1.473

2003-05-01

Journal of Emergency Medicine

Abstract:

What problem does this paper attempt to address?

Small airway dysfunction in patients after mild COVID-19

Beuter,H.,Nichici,T.,Stanko,K.,Russ,A.-K.,Reinke,L.,Nürnberger,C.,Störk,S.,Zoller,T.,Steinbeis,F.,Heim,E.,Hopff,S. M.,Vehreschild,J. J.,Heuschmann,P. U.,Lieb,W.,Franzpötter,K.,Poick,S.,Krawczak,M.,Abdo,M.,Rabe,K. F.,Heyckendorf,J.,Schreiber,S.,Kirsten,A.-M.,Bahmer,T.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5259

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Background : Small airway dysfunction (SAD) might be a feature of Post-COVID syndrome (PCS). SAD can be assessed by impulse oscillometry (IOS) in a tidal breathing maneuver, or by body plethysmography (BP) and forced spirometry (FS), both of which depend on investigator skill and patient adherence. Objective : We aimed to investigate the extent of SAD in PCS patients, who were severity graded by self-reported symptoms using a PCS score (PCSS, Bahmer et al., eClinicalMedicine, 2022). Methods : The multicenter, prospective COVIDOM study investigates sequelae of PCR-confirmed SARS-CoV-2 infections in individuals ≥6 months after acute COVID-19. IOS, BP and FS were performed according to ERS guidelines investigating frequency dependence of resistance (FDR abs / R 5-20Hz ), RV/TLC, and FEV 1 /FVC. According to the PCSS, participants were grouped into none/mild (I), moderate (II) and severe PCS (III). Results : We included 2,811 valid lung function results in our analysis. 8.8% showed airflow limitation (FEV 1 /FVC ULN) (GLI 2012 reference values) and 40.5 % increased FDR abs (>0.03kPa/l/s). Comparing PCS-I to PCS-II and PCS-III, the z-score for FEV 1 /FVC (–0.36±1.08; –0.37±0.95; –0.30±1.01, p>0.05) did not differ between groups while the z-score for RV/TLC (0.77±1.25; 0.82±1.1; 0.90±1.18, p=0.03) and FDR abs displayed significant differences (0.032±0.08; 0.033±0.06; 0.043±0.06, p=0.001). Conclusion : Self-reported PCS severity was associated with SAD as assessed by IOS and BP. IOS needs little expertise in lung function testing and could therefore easily be integrated in PCS assessment. Despite broad availability, FEV 1 might be insensitive to the subtle changes of airway physiology in affected individuals.

respiratory system
School nursing: an investment in the future.

S. Anderson,C. Burbach,P. Rawlins

1994-06-01

Abstract:
Small-airway Dysfunction among Non-Cystic Bronchiectasis Patients with Different Bronchiectasis Severity Index

Cuiyan Tan,Donghai Ma,Changli Tu,Meizhu Chen,Kongqiu Wang,Xiaobin Zheng,Yiying Huang,Zhenguo Wang,Jian Wu,Jin Huang,Jing Liu

DOI: https://doi.org/10.1183/13993003.congress-2021.pa2072

2021-01-01

Abstract:Introduction: In bronchiectasis, small airway abnormalities like “tree-in-bud pattern” sign are commonly recognised in peripheral airway through HRCT scans. Nevertheless, impulse oscillometry (IOS), as an alternative method, can easily measure the lung and bronchial functional characteristics, including both the proximal and distal airways. This study aims to investigate the relevance of small airway dysfunction (SAD) in bronchiectasis and its role in the severity of bronchiectasis. Materials and methods: We prospectively enrolled 134 patients with bronchiectasis referred to a University Hospital of Zhuhai. We considered that a patient had small airway dysfunction (SAD) when R5-R20>0.07kPa*s/L. The severity of bronchiectasis was assessed using the Bronchiectasis Severity Index (BSI) and was stratified into mild, moderate, and severe. Correlations between the IOS indicator and spirometry data were analysed. Results: Of the134 bronchiectasis patients, 60 (45%) presented small airway dysfunctions assessed by the IOS indicator. In bronchiectasis with SAD, the percentage of mild, moderate, and severe was 45%, 38%, and 17%, respectively. A strong correlation was observed between the maximal mid expiratory flow (MMEF) and R5-R20 value (r=-0.73, p<0.0001). Conclusion: In non-cystic bronchiectasis, a large proportion of patients present small airway dysfunction assessed by the IOS indicator R5-R20. The small airway dysfunction is present across patients with all severities of bronchiectasis, even in the mild degree.
Clinico-radiological and pulmonary function assessment of post-COVID-19 patients with respiratory symptoms

Nilakantha Behera,Jeetendra Kumar Patra,Bijay Kumar Dash,Manoranjan Pattnaik,Deepak Sahu,Bayyaram Rambhoopal Reddy

DOI: https://doi.org/10.4103/jfmpc.jfmpc_1721_23

Abstract:Background: Respiratory symptoms may persist for several weeks following the initial coronavirus disease 2019 (COVID-19) infection. The aims and objectives were to assess the clinical symptoms, pulmonary functions, and radiological changes and to assess the cardio-vascular complications in post-COVID-19 patients. Methods: This observational study was conducted in the Department of Pulmonary Medicine in collaboration with the Department of Cardiology, SCBMCH, Cuttack, from March 2021 to August 2022 on 75 post-COVID-19 patients with respiratory symptoms from 4 weeks to 2 years after treatment for COVID-19 infection. Post-COVID patients having previous respiratory diseases were excluded from the study. Results: Among 75 patients, the most common age group was 18-30 years with a male-to-female ratio of 2.5:1. Based on O2 requirement, patients were divided into the mild symptomatic group and moderate to severe pneumonia group. The most common respiratory symptom was dyspnea, followed by cough with expectoration. Bilateral crepitations were found in 17% of cases. C-reactive protein (CRP) and D-dimer were increased in 38.6% and 32% of patients, respectively. 42.6% had abnormal chest X-ray, and the most common abnormal finding was reticular thickening. In spirometry, the restrictive pattern and mixed pattern were the predominant types documented in 49.3% and 13.3% of cases, respectively, which were significant in the moderate-severe group. Diffusion capacity of the lungs for carbon monoxide (DLCO) was performed in only 19 patients (mild group 13 and moderate-severe group 6). Twelve (63.2%) patients had abnormal DLCO. P- values were significant for RV (0.0482) and RV/TLC (0.0394). High-resolution computed tomography (HRCT) of the thorax was abnormal in 55.7% with the most common abnormalities as inter- and intra-lobular septal thickening. The left ventricular ejection fraction was preserved in all patients, with right atrium and right ventricle enlargement in 2.6% and pulmonary hypertension in 4.0% of participants. Conclusion: All post-COVID-19 patients having respiratory symptoms after recovery from acute COVID-19 may be referred by family care physicians to a dedicated post-COVID center for further evaluation, management, and early rehabilitation to decrease the morbidity in recovered patients. Persistent increased blood parameters like TLC, N/L ratio, RBS, CRP, and D-dimer seen in recovered post-COVID-19 patients. The long-term impact of CT findings on respiratory symptoms, pulmonary functions, and quality of life is unknown. Cardiovascular abnormalities in post-COVID-19 patients are infrequent.
Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Oriol Sibila,Lídia Perea,Núria Albacar,Jorge Moisés,Tamara Cruz,Núria Mendoza,Belen Solarat,Gemma Lledó,Gerard Espinosa,Joan Albert Barberà,Joan Ramon Badia,Alvar Agustí,Jacobo Sellarés,Rosa Faner

DOI: https://doi.org/10.1186/s12931-022-01955-5

IF: 5.8

2022-02-21

Respiratory Research

Abstract:Abstract Background Some COVID-19 survivors present lung function abnormalities during follow-up, particularly reduced carbon monoxide lung diffusing capacity (DLCO). To investigate risk factors and underlying pathophysiology, we compared the clinical characteristics and levels of circulating pulmonary epithelial and endothelial markers in COVID-19 survivors with normal or reduced DLCO 6 months after discharge. Methods Prospective, observational study. Clinical characteristics during hospitalization, and spirometry, DLCO and plasma levels of epithelial (surfactant protein (SP) A (SP-A), SP-D, Club cell secretory protein-16 (CC16) and secretory leukocyte protease inhibitor (SLPI)), and endothelial (soluble intercellular adhesion molecule 1 (sICAM-1), soluble E-selectin and Angiopoietin-2) 6 months after hospital discharge were determined in 215 COVID-19 survivors. Results DLCO was < 80% ref. in 125 (58%) of patients, who were older, more frequently smokers, had hypertension, suffered more severe COVID-19 during hospitalization and refer persistent dyspnoea 6 months after discharge. Multivariate regression analysis showed that age ≥ 60 years and severity score of the acute episode ≥ 6 were independent risk factors of reduced DLCO 6 months after discharge . Levels of epithelial (SP-A, SP-D and SLPI) and endothelial (sICAM-1 and angiopoietin-2) markers were higher in patients with reduced DLCO, particularly in those with DLCO ≤ 50% ref. Circulating SP-A levels were associated with the occurrence of acute respiratory distress syndrome (ARDS), organizing pneumonia and pulmonary embolisms during hospitalization. Conclusions Reduced DLCO is common in COVID-19 survivors 6 months after hospital discharge, especially in those older than 60 years with very severe acute disease. In these individuals, elevated levels of epithelial and endothelial markers suggest persistent lung damage.

respiratory system
EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME

Jéssica Gabriela Messias Oliveira,Renan Pereira Campos,Beatriz Luiza Pinheiro Alves Azevedo,Samantha Gomes de Alegria,Thiago Thomaz Mafort,Agnaldo José Lopes

DOI: https://doi.org/10.1016/j.bjpt.2024.100790

IF: 4.762

2024-04-01

Brazilian Journal of Physical Therapy

Abstract:Background In addition to deconditioning, persistent low-grade inflammation following acute SARS-CoV-2 infection may contribute to systemic problems, which supports the need for further assessment of cardiopulmonary conditioning. In fact, the impairment of the respiratory system in the acute phase of COVID-19 has the potential to significantly impact functional capacity in patients with post-COVID-19 syndrome (PCS), with dynamic hyperinflation (DH) and reduced ventilatory reserve (RV). Objective To investigate the dynamic ventilatory responses and their influence on the functional capacity to exercise in these patients. Methods Between March and October 2022, a cross-sectional study was carried out with 16 patients with PCS aged ≥18 years attended at the Piquet Carneiro Polyclinica, at the State University of Rio de Janeiro. Patients with a history of COVID-19 pneumonia with persistence of respiratory symptoms after 3 months of the acute phase were included. Patients without a previous diagnosis of COVID-19 confirmed by RT-PCR (reverse-transcription polymerase chain reaction) and those who failed to perform the protocol tests were excluded. Patients underwent impulse oscillometry (IOS), spirometry, 6-minute walk test (6MWT) with Spiropalm®-6MWT, and cardiopulmonary exercise test (CPET). A ≥100 ml decrease in inspiratory capacity (IC) during exercise was defined as HD. Ventilatory reserve (VR) indicates how close minute ventilation (VE) approaches maximum voluntary ventilation (MVV) during a given activity and was calculated as the difference between MVV and VEpeak ([MVV-VEpeak]/MVV); VR <30% was considered to be ventilatory limitation on exertion. Results Median age and time since diagnosis of COVID-19 were 57 (50–59) years and 98 (93–106) days, respectively. Regarding spirometry, 12.5% and 50% of the participants had an abnormal spirometry and an altered IOS, respectively, and the difference in resistance between 4 Hz and 20 Hz (R4-R20) was detected in 31.2% of the participants. cases. Regarding cardiopulmonary performance during exercise, the median distance in the 6MWT was 83 (78–97) % of predicted, with HD and VR <30% observed in 62.5% and 12.5% of participants, respectively. In CPET, the median peak oxygen consumption (VO2peak) was 19 (14–37) ml/kg/min. There was a significant correlation of the distance covered in the 6MWT with both R4-R20 (rs = -0.499, P = 0.039) and VO2peak (rs = 0.628, P = 0.009). Conclusion Our findings suggest that HD and, to a lesser extent, low VR are contributors to poor exercise performance that is associated with peripheral airway disease. Implications Based on these results, we obtained precise ventilatory and metabolic measurements, which we can consider as an important factor for more assertive exercise prescription during the rehabilitation of these patients. Moreover, these results are promising if we consider that they were obtained with simple, cheap, and portable ventilatory and metabolic measurement systems, easily applicable in real-world environments.

rehabilitation,orthopedics
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Xiaojun Wu,Xiaofan Liu,Yilu Zhou,Hongying Yu,Ruiyun Li,Qingyuan Zhan,Fang Ni,Si Fang,Yang Lu,Xuhong Ding,Hailing Liu,Rob M Ewing,Mark G Jones,Yi Hu,Hanxiang Nie,Yihua Wang

DOI: https://doi.org/10.1016/S2213-2600(21)00174-0

Abstract:Background: The consequences of COVID-19 in those who recover from acute infection requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal trends in respiratory outcomes over 12 months in patients hospitalised for severe COVID-19 and to investigate the associated risk factors. Methods: In this prospective, longitudinal, cohort study, patients admitted to hospital for severe COVID-19 who did not require mechanical ventilation were prospectively followed up at 3 months, 6 months, 9 months, and 12 months after discharge from Renmin Hospital of Wuhan University, Wuhan, China. Patients with a history of hypertension; diabetes; cardiovascular disease; cancer; and chronic lung disease, including asthma or chronic obstructive pulmonary disease; or a history of smoking documented at time of hospital admission were excluded at time of electronic case-note review. Patients who required intubation and mechanical ventilation were excluded given the potential for the consequences of mechanical ventilation itself to influence the factors under investigation. During the follow-up visits, patients were interviewed and underwent physical examination, routine blood test, pulmonary function tests (ie, diffusing capacity of the lungs for carbon monoxide [DLCO]; forced expiratory flow between 25% and 75% of forced vital capacity [FVC]; functional residual capacity; FVC; FEV1; residual volume; total lung capacity; and vital capacity), chest high-resolution CT (HRCT), and 6-min walk distance test, as well as assessment using a modified Medical Research Council dyspnoea scale (mMRC). Findings: Between Feb 1, and March 31, 2020, of 135 eligible patients, 83 (61%) patients participated in this study. The median age of participants was 60 years (IQR 52-66). Temporal improvement in pulmonary physiology and exercise capacity was observed in most patients; however, persistent physiological and radiographic abnormalities remained in some patients with COVID-19 at 12 months after discharge. We found a significant reduction in DLCO over the study period, with a median of 77% of predicted (IQR 67-87) at 3 months, 76% of predicted (68-90) at 6 months, and 88% of predicted (78-101) at 12 months after discharge. At 12 months after discharge, radiological changes persisted in 20 (24%) patients. Multivariate logistic regression showed increasing odds of impaired DLCO associated with female sex (odds ratio 8·61 [95% CI 2·83-26·2; p=0·0002) and radiological abnormalities were associated with peak HRCT pneumonia scores during hospitalisation (1·36 [1·13-1·62]; p=0·0009). Interpretation: In most patients who recovered from severe COVID-19, dyspnoea scores and exercise capacity improved over time; however, in a subgroup of patients at 12 months we found evidence of persistent physiological and radiographic change. A unified pathway for the respiratory follow-up of patients with COVID-19 is required. Funding: National Natural Science Foundation of China, UK Medical Research Council, and National Institute for Health Research Southampton Biomedical Research Centre. Translation: For the Chinese translation of the abstract see Supplementary Materials section.
Evidence for a fourth rat isoform of the plasma membrane calcium pump in the kidney.

J. Gonzalez,W. Dalmeida,J. Abramowitz,W. Suki

DOI: https://doi.org/10.1016/0006-291X(92)91205-5

1992-04-15

Abstract:
Ventilatory efficiency in long-term dyspnoeic patients following COVID-19 pneumonia

Daniel Piamonti,Luigi Panza,Roberto Flore,Valentina Baccolini,Daniela Pellegrino,Arianna Sanna,Altea Lecci,Giulia Lo Muzio,Dario Angelone,Flavio Marco Mirabelli,Matteo Morviducci,Paolo Onorati,Emanuele Messina,Valeria Panebianco,Carlo Catalano,Matteo Bonini,Paolo Palange

DOI: https://doi.org/10.1016/j.resp.2024.104285

IF: 2.821

2024-06-02

Respiratory Physiology & Neurobiology

Abstract:Background Long COVID is defined as persistency of symptoms, such as exertional dyspnea, twelve weeks after recovery from SARS-CoV-2 infection. Objectives To investigate ventilatory efficiency by the use of cardiopulmonary exercise testing (CPET) in patients with exertional dyspnea despite normal basal spirometry after 18 (T 18 ) and 36 months (T 36 ) from COVID-19 pneumonia. Methods One hundred patients with moderate-critical COVID-19 were prospectively enrolled in our Long COVID program. Medical history, physical examination and lung high-resolution computed tomography (HRCT) were obtained at hospitalization (T 0 ), 3 (T 3 ) and 15 months (T 15 ). All HRCTs were revised using a semi-quantitative CT severity score (CSS). Pulmonary function tests were obtained at T 3 and T 15 . CPET was performed in a subset of patients with residual dyspnea (mMRC ≥ 1), at T 18 and at T 36 . Results Remarkably, at CPET, ventilatory efficiency was reduced both at T 18 (V' E /V'CO 2 slope = 31.4±3.9 SD) and T 36 (V' E /V'CO 2 slope = 31.28±3.70 SD). Furthermore, we identified positive correlations between V' E /V'CO 2 slope at T 18 and T 36 and both percentage of involvement and CSS at HRCT at T 0 , T 3 and T 15 . Also, negative linear correlations were found between V' E /V'CO 2 slope at T 18 and T 36 and DL CO at T 3 and T 15 . Conclusions At eighteen months from COVID-19 pneumonia, 20% of subjects still complains of exertional dyspnea. At CPET this may be explained by persistently reduced ventilatory efficiency, possibly related to the degree of lung parenchymal involvement in the acute phase of infection, likely reflecting a damage in the pulmonary circulation.

physiology,respiratory system
FOT Technique Applied for Monitoring of COVID-19 Pneumonia Reveals Small Airways Involvement

Immanuels Taivans,Laura Grima,Normunds Jurka,Ligita Zvaigzne,Valentina Gordjušina,Gunta Strazda

DOI: https://doi.org/10.3390/diagnostics14111160

IF: 3.6

2024-06-01

Diagnostics

Abstract:The fact that some SARS-CoV-2 pneumonia patients benefit from changing body position, and some from continuous positive airways pressure (CPAP), indicates the functional character of hypoxia. We hypothesize that such effects could be explained by the closure of small airways. To prove the hypothesis, we evaluated the patency of small airways in 30 oxygen-dependent, spontaneously breathing patients with SARS-CoV-2 pneumonia during their hospital stay using the FOT method and then compared the results with data obtained three months later. During the acute period, total resistance (R5) and peripheral resistance (R5-20) rose above the upper limit of normal (ULN) in 28% and 50% of all patients, respectively. Reactance indices X5, AX and Fres exceeded ULN in 55%, 68% and 66% of cases. Significant correlations were observed between PaO2/FiO2, the time spent in the hospital and R5, X5, AX and Fres. After 3 months, 18 patients were re-examined. During the hospital stay, 11 of them had risen above the upper limit of normal (ULN), for both resistance (R5-20) and reactance (X5, AX) values. Three months later, ULN for R5-20 was exceeded in only four individuals, but ULN for X5 and AX was exceeded in five individuals. Lung function examination revealed a combined restrictive/obstructive ventilatory failure and reduced CO transfer factor. We interpret these changes as lung tissue remodeling due to the process of fibrosis. We conclude that during acute period of SARS-CoV-2 pneumonia, dilated pulmonary blood vessels and parenchymal oedema induce functional closure of small airways, which in turn induce atelectasis with pulmonary right-to-left shunting, followed by the resulting hypoxemia.

medicine, general & internal
Focusing on the long-term recovery of severe acute respiratory syndrome coronavirus 2 infection: Clinically relevant observations

Chunxia Wang,Yucai Zhang

DOI: https://doi.org/10.1002/ctd2.99

Abstract:Background: The long-term implications of COVID-19 attract global attention in the post-COVID-19 pandemic era. Impaired lung function is the main sequelae in adults' survivors of SARS-CoV-2 infection. Methods and results: The plasma proteomic pattern provides novel evidence on multiple biological domains relevant to monitoring lung function and targeting the clinical application in adults with acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 infection (SARS-CoV-2-ARDS). Preliminary studies support the evidence of pulmonary function tests (PFT) and computed tomography (CT) scan as routine follow-up tools. Combining the early fibrotic indicators and D-dimer levels could prove the validity and reliability of the proactive management of lung function assessment during the long-term recovery in SARS-CoV-2 infection. Conclusion: In summary, protocolized PFT and CT scan and effective biomarkers for early fibrotic changes should be applied to clinical practice during the long follow-up in patients with severe COVID-19.
Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction

Po-Chun Lo,Jia-Yih Feng,Yi-Han Hsiao,Kang-Cheng Su,Kun-Ta Chou,Yuh-Min Chen,Hsin-Kuo Ko,Diahn-Warng Perng

DOI: https://doi.org/10.1186/s12931-024-02830-1

IF: 5.8

2024-05-17

Respiratory Research

Abstract:Limited research has investigated the relationship between small airway dysfunction (SAD) and static lung hyperinflation (SLH) in patients with post-acute sequelae of COVID-19 (PASC) especially dyspnea and fatigue.

respiratory system
Laser-induced shock wave can spark triboluminescence of amorphous sugars.

Yasuyuki Tsuboi,T. Seto,N. Kitamura

DOI: https://doi.org/10.1021/jp8002504

2008-06-27

Abstract:We investigated the triboluminescence (TL) of sugars using an innovative experimental approach: the laser-induced shock wave (LISW) technique. We found that the LISW could induce very bright TL in crystalline sugars, the intensity of which was shown to be 10(5) times higher than that obtained by conventional manual hand rubbing. We also applied the LISW technique to amorphous sugar samples. Although it was supposed that TL could not be excited in amorphous solids of sugars having isotropic structures, we revealed that LISW could induce bright TL in amorphous sugars similar to that induced in crystalline sugars. On the basis of the experimental results showing the dynamic behavior of the sample fracture combined with those of the TL, we discuss these novel TL mechanisms in sugars. We believe that the shock wave technique opens a new channel for investigating the nature of TL.
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19

Mark Philip Cassar,Elizabeth M Tunnicliffe,Nayia Petousi,Adam J Lewandowski,Cheng Xie,Masliza Mahmod,Azlan Helmy Abd Samat,Rachael A Evans,Christopher E Brightling,Ling-Pei Ho,Stefan K Piechnik,Nick P Talbot,David Holdsworth,Vanessa M Ferreira,Stefan Neubauer,Betty Raman,Elizabeth M. Tunnicliffe,Adam J. Lewandowski,Rachael A. Evans,Christopher E. Brightling,Stefan K. Piechnik,Nick P. Talbot,Vanessa M. Ferreira

DOI: https://doi.org/10.1016/j.eclinm.2021.101159

IF: 15.1

2021-11-01

EClinicalMedicine

Abstract:BACKGROUND: The longitudinal trajectories of cardiopulmonary abnormalities and symptoms following infection with coronavirus disease (COVID-19) are unclear. We sought to describe their natural history in previously hospitalised patients, compare this with controls, and assess the relationship between symptoms and cardiopulmonary impairment at 6 months post-COVID-19.METHODS: Fifty-eight patients and thirty matched controls (single visit), recruited between 14th March - 25th May 2020, underwent symptom-questionnaires, cardiac and lung magnetic resonance imaging (CMR), cardiopulmonary exercise test (CPET), and spirometry at 3 months following COVID-19. Of them, forty-six patients returned for follow-up assessments at 6 months.FINDINGS: At 2-3 months, 83% of patients had at least one cardiopulmonary symptom versus 33% of controls. Patients and controls had comparable biventricular volumes and function. Native cardiac T1 (marker of fibroinflammation) and late gadolinium enhancement (LGE, marker of focal fibrosis) were increased in patients at 2-3 months. Sixty percent of patients had lung parenchymal abnormalities on CMR and 55% had reduced peak oxygen consumption (pV̇O2) on CPET. By 6 months, 52% of patients remained symptomatic. On CMR, indexed right ventricular (RV) end-diastolic volume (-4·3 mls/m2, P=0·005) decreased and RV ejection fraction (+3·2%, P=0·0003) increased. Native T1 and LGE improved and was comparable to controls. Lung parenchymal abnormalities and peak V̇O2, although better, were abnormal in patients versus controls. 31% had reduced pV̇O2 secondary to symptomatic limitation and muscular impairment. Cardiopulmonary symptoms in patients did not associate with CMR, lung function, or CPET measures.INTERPRETATION: In patients, cardiopulmonary abnormalities improve over time, though some measures remain abnormal relative to controls. Persistent symptoms at 6 months post-COVID-19 did not associate with objective measures of cardiopulmonary health.FUNDING: The authors' work was supported by the NIHR Oxford Biomedical Research Centre, Oxford British Heart Foundation (BHF) Centre of Research Excellence (RE/18/3/34214), United Kingdom Research Innovation and Wellcome Trust. This project is part of a tier 3 study (C-MORE) within the collaborative research programme entitled PHOSP-COVID Post-hospitalization COVID-19 study: a national consortium to understand and improve long-term health outcomes, funded by the Medical Research Council and Department of Health and Social Care/National Institute for Health Research Grant (MR/V027859/1) ISRCTN number 10980107.
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Antoine Beurnier,Laurent Savale,Xavier Jaïs,Romain Colle,Tai Pham,Luc Morin,Sophie Bulifon,Nicolas Noël,Athénaïs Boucly,Benoit Delbarre,Nathan Ebstein,Samy Figueiredo,Matthieu Gasnier,Anatole Harrois,Etienne-Marie Jutant,Mitja Jevnikar,Sophia Keddache,Anne-Lise Lecoq,Olivier Meyrignac,Florence Parent,Jérémie Pichon,Mariana Preda,Anne Roche,Andrei Seferian,Marie-France Bellin,Thomas Gille,Emmanuelle Corruble,Olivier Sitbon,Laurent Becquemont,Xavier Monnet,Marc Humbert,David Montani,and the Comebac Investigators,Comebac Investigators

DOI: https://doi.org/10.1183/23120541.00063-2023

2023-05-02

Abstract:Background: Dyspnoea is a common persistent symptom after COVID-19. Whether it is associated with functional respiratory disorders remains unclear. Methods: We assessed the proportion and characteristics of patients with "functional respiratory complaints" (FRCs) (as defined by Nijmegen Questionnaire >22) among 177 post-COVID-19 individuals who benefited from outclinic evaluation in the COMEBAC study (i.e., symptomatic and/or intensive care unit (ICU) survivors at 4 months). In a distinct explanatory cohort of 21 consecutive individuals with unexplained post-COVID-19 dyspnoea after routine tests, we also analysed the physiological responses to incremental cardiopulmonary exercise testing (CPET). Findings: In the COMEBAC cohort, 37 patients had significant FRCs (20.9%, IC95: 14.9-26.9). The prevalence of FRCs ranged from 7.2% (ICU patients) to 37.5% (non-ICU patients). The presence of FRCs was significantly associated with more severe dyspnoea, lower 6-min walk distance, more frequent psychological and neurological symptoms (cognitive complaint, anxiety, depression, insomnia and post-traumatic stress disorders) and poorer quality of life (all p<0.01). In the explanatory cohort, seven out of 21 patients had significant FRCs. Based on CPET, dysfunctional breathing was identified in 12 out of 21 patients, five out of 21 had normal CPET, three out of 21 had deconditioning and one out of 21 had evidence of uncontrolled cardiovascular disease. Interpretation: FRCs are common during post-COVID-19 follow-up, especially among patients with unexplained dyspnoea. Diagnosis of dysfunctional breathing should be considered in those cases.
Readability of Pediatric Patient Education Materials

Carol Klingbeil,M. Speece,H. Schubiner

DOI: https://doi.org/10.1177/000992289503400206

1995-02-01

Abstract:Written patient education materials are an important part of ambulatory pediatric practices. We evaluated the readability of 33 representative pediatric education materials using three common formulas: Fog, Fry, and SMOG. The majority of pamphlets had readabilities of grade nine or above. The need to use multiple readability formulas was also demonstrated. Although the three readability formulas were highly correlated, they were significantly different from each other when using a repeated measures analysis of variance (ANOVA) design. In almost half, the readability estimates differed by at least two grade levels. In addition, a large intrapamphlet variability for some pamphlets suggests a need to focus more attention on the readability of multiple sections within a pamphlet, not only on the overall or average readability. We conclude that the readability levels of patient education materials continue to be too high.
Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort Three Years after Severe COVID-19 Infection

Scarlett O Murphy,Claire F McGroder,Mary M Salvatore,Belinda M D'Souza,Kathleen M Capaccione,Anjali Saqi,Faisal Shaikh,Shannon Benesh,David Zhang,Matthew R Baldwin,Christine Kim Garcia

DOI: https://doi.org/10.1101/2024.10.16.24315602

2024-10-17

Abstract:Fibrotic-like abnormalities are present in 60% of a single-center, longitudinal, multi-ethnic cohort 3-years after severe COVID-19. They are independently associated with male sex, low BMI, shorter telomere length, increased severity of illness, and mechanical ventilation; Black race and asthma are protective. Participants with fibrotic-like abnormalities are more likely to have reduced diffusion capacity and 6-minute walk distance. Fibrotic-like abnormalities persist but modestly improve over time. Transbronchial biopsies show small airways histopathology, consistent with high prevalence of air trapping in expiration, and infrequent interstitial thickening. This study highlights the need for continued monitoring of patients with persistent fibrosis after severe COVID-19.

Respiratory Medicine
Bronchodilator response in Post-COVID-19 patients undergoing pulmonary rehabilitation

Simon Alexander Krooss,Isabel Klefenz,Michael Ott,Frank Klawonn,Daniela Leitl,Tessa Schneeberger,Inga Jarosch,Claus Franz Vogelmeier,Marek Lommatzsch,Rainer Gloeckl,Andreas Rembert Koczulla

DOI: https://doi.org/10.1159/000540297

2024-07-18

Respiration

Abstract:Introduction: SARS-CoV-2 infections can result in a broad spectrum of symptoms from mild to life-threatening. Long-term consequences on lung function are not well understood yet. Methods: In our study, we have examined 134 post-COVID patients (aged 54.83±14.4 years) with dyspnea on exertion as a leading symptom 6 weeks to 24 months after a SARS-CoV-2 infection for bronchodilator responsiveness during their stay in our pulmonary rehabilitation clinic. Results: Prior to bronchial dilation, six out of 134 patients (4.47%) presented an FEV1/FVC ratio below lower limit of normal (Z-score=-1.645) indicative of an obstructive airway disease. Following inhalation of a ß2-adrenergic agonist we measured a mean FEV1 increase of 181.5 mL in our cohort, which was significantly elevated compared to a historical control group (ΔFEV1 = 118 mL). 28.7% of the patients showed an increase greater than 200 mL and 12% displayed a significant bronchodilation response (>200 mL ΔFEV1 and >12% FEV1 increase). Interestingly, no significant difference in bronchial dilation effect was observed when comparing patients hospitalized and those non-hospitalized during the course of their SARS-CoV-2 infection. Conclusion: Our data provides evidence for increased prevalence of obstructive ventilatory defects and increased bronchodilator responsiveness in patients with persisting symptoms after COVID-19. Depending on the extent of this complication, post-COVID patients may benefit from an adapted ß2-inhalation therapy including subsequent reevaluation.

respiratory system
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Davies Adeloye,Omer Elneima,Luke Daines,Krisnah Poinasamy,Jennifer K Quint,Samantha Walker,Chris E Brightling,Salman Siddiqui,John R Hurst,James D Chalmers,Paul E Pfeffer,Petr Novotny,Thomas M Drake,Liam G Heaney,Igor Rudan,Aziz Sheikh,Anthony De Soyza,International COVID-19 Airways Diseases Group,Mohammad Abdollahi,Dhiraj Agarwal,Riyad Al-Lehebi,Peter J Barnes,Jagadeesh Bayry,Marcel Bonay,Louis J Bont,Arnaud Bourdin,Thomas Brown,Gaetano Caramori,Amy Hai Yan Chan,David H Dockrell,Simon Doe,Jamie Duckers,Anthony D'Urzo,Magnus Ekström,Cristóbal Esteban,Catherine M Greene,Atul Gupta,Jennifer L Ingram,Ee Ming Khoo,Fanny Wai San Ko,Gerard H Koppelman,Brian J Lipworth,Karin Lisspers,Michael Loebinger,Jose Luis Lopez-Campos,Matthew Maddocks,David Mannino,Miguel A Martinez-Garcia,Renae Mcnamara,Marc Miravitlles,Pisirai Ndarukwa,Alison Pooler,Chin Kook Rhee,Peter Schwarz,Dominick Shaw,Michael Steiner,Andrew Tai,Charlotte Suppli Ulrik,Paul Walker,Michelle C Williams

DOI: https://doi.org/10.1016/S2213-2600(21)00286-1

Abstract:Persistent ill health after acute COVID-19-referred to as long COVID, the post-acute COVID-19 syndrome, or the post-COVID-19 condition-has emerged as a major concern. We undertook an international consensus exercise to identify research priorities with the aim of understanding the long-term effects of acute COVID-19, with a focus on people with pre-existing airways disease and the occurrence of new-onset airways disease and associated symptoms. 202 international experts were invited to submit a minimum of three research ideas. After a two-phase internal review process, a final list of 98 research topics was scored by 48 experts. Patients with pre-existing or post-COVID-19 airways disease contributed to the exercise by weighting selected criteria. The highest-ranked research idea focused on investigation of the relationship between prognostic scores at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease. High priority was also assigned to comparisons of the prevalence and severity of post-COVID-19 fatigue, sarcopenia, anxiety, depression, and risk of future cardiovascular complications in patients with and without pre-existing airways disease. Our approach has enabled development of a set of priorities that could inform future research studies and funding decisions. This prioritisation process could also be adapted to other, non-respiratory aspects of long COVID.
Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management

Artur Fedorowski,Monika Fagevik Olsén,Frida Nikesjö,Christer Janson,Judith Bruchfeld,Maria Lerm,Kristofer Hedman

DOI: https://doi.org/10.1111/joim.13652

Abstract:A significant proportion of COVID-19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately 1 out of 10 COVID-19 convalescents reports persistent health issues more than 3 months after initial recovery. This 'post-COVID-19 condition' may include a large variety of symptoms from almost all domains and organs, and for some patients it may mean prolonged sick-leave, homestay and strongly limited activities of daily life. In this narrative review, we focus on the symptoms and signs of post-COVID-19 condition in adults - particularly those associated with cardiovascular and respiratory systems, such as postural orthostatic tachycardia syndrome or airway disorders - and explore the evidence for chronic autonomic dysfunction as a potential underlying mechanism. The most plausible hypotheses regarding cellular and molecular mechanisms behind the wide spectrum of observed symptoms - such as lingering viruses, persistent inflammation, impairment in oxygen sensing systems and circulating antibodies directed to blood pressure regulatory components - are discussed. In addition, an overview of currently available pharmacological and non-pharmacological treatment options is presented.

Atraumatic Clostridial myonecrosis: case report and literature review.

Small airway dysfunction in patients after mild COVID-19

School nursing: an investment in the future.

Small-airway Dysfunction among Non-Cystic Bronchiectasis Patients with Different Bronchiectasis Severity Index

Clinico-radiological and pulmonary function assessment of post-COVID-19 patients with respiratory symptoms

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Evidence for a fourth rat isoform of the plasma membrane calcium pump in the kidney.

Ventilatory efficiency in long-term dyspnoeic patients following COVID-19 pneumonia

FOT Technique Applied for Monitoring of COVID-19 Pneumonia Reveals Small Airways Involvement

Focusing on the long-term recovery of severe acute respiratory syndrome coronavirus 2 infection: Clinically relevant observations

Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction

Laser-induced shock wave can spark triboluminescence of amorphous sugars.

Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Readability of Pediatric Patient Education Materials

Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort Three Years after Severe COVID-19 Infection

Bronchodilator response in Post-COVID-19 patients undergoing pulmonary rehabilitation

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management